Skip to main content
. 2020 Dec 11;23(1):140–148. doi: 10.1016/j.neo.2020.11.010

Figure 4.

Fig. 4

BCL-2 staining of the U-RT1 cell line (B) and the lymph node with the diffuse large B-cell lymphoma from which the cell line was established (A). Both the cell line and the lymphoma show immunoreactivity for the BCL-2 antibody. The black line indicates 50 µm.